Pre-clinical safety and efficacy of TA-CIN, a recombinant HPV16 L2E6E7 fusion protein vaccine, in homologous and heterologous prime-boost regimens

✍ Scribed by S.H. van der Burg; K.M.C. Kwappenberg; T. O'Neill; R.M.P. Brandt; C.J.M. Melief; J.K. Hickling; R. Offringa

• Book ID: 117430385
• Publisher: Elsevier Science
• Year: 2001
• Tongue: English
• Weight: 190 KB
• Volume: 19
• Category: Article
• ISSN: 0264-410X
• DOI: 10.1016/s0264-410x(01)00086-x